Vulvar reconstruction in vulvar cancer: "lotus petal" suprafascial flap

The purposes of this study are to demonstrate our experience in using the "lotus petal" suprafascial flap and to evaluate the postoperative complications. During the period ranging from July 2012 to March 2015, nine patients diagnosed with primary or recurrent vulvar cancer have undergone...

Descripción completa

Detalles Bibliográficos
Autores: Roda, JLH, Abella, JAL, Maazouzi, Y, Babiloni, AB, Mota, AC, Colomer, MG, Rubert, AS
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2016
País:España
Institución:Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
Repositorio:r-FISABIO. Repositorio Institucional de Producción Científica
OAI Identifier:oai:fisabio.fundanetsuite.com:p15972
Acceso en línea:https://fisabio.portalinvestigacion.com/publicaciones/15972
Access Level:acceso abierto
Palabra clave:Vulvar cancer
Vulvectomy
Vulvar reconstruction
Lotus petal flap
Descripción
Sumario:The purposes of this study are to demonstrate our experience in using the "lotus petal" suprafascial flap and to evaluate the postoperative complications. During the period ranging from July 2012 to March 2015, nine patients diagnosed with primary or recurrent vulvar cancer have undergone radical vulvectomy followed by reconstructive surgery. Seventeen lotus petal suprafascial flap surgeries were performed. The average age of the patients was 79 years. No intraoperative complications were reported. The surgery length was 180 min with an estimated blood loss of 400 cc. Severe postoperative complications were rare. There were no complications associated with the donor site, nor were there any losses due to total or partial flap tissue necrosis. There were 2 (22.2 %) cases of partial wound dehiscence, which did not require re-intervention. The lotus petal suprafascial flap is a simple procedure that can be done during the same surgery as the radical vulvectomy, improving the aesthetic results and reducing both the rate of complications and hospital stay.